Dr. Kenji Matsumoto, PhD
Peptide Immunology Research Lead
Peptide Immunology Research Lead
Dr. Kenji Matsumoto received his PhD in Immunology from Osaka University and completed postdoctoral training at the National Institutes of Health (NIH). His research focuses on peptide-based vaccines and immunomodulatory peptides for autoimmune conditions. He has contributed to 3 peptide vaccine candidates currently in clinical trials.
PhD Immunology, Osaka University; Postdoc, NIH/NIAID
Peptide vaccines, immunomodulation, autoimmune therapeutics
Peptide vaccine adjuvant design, T-cell epitope mapping, Autoimmune peptide therapy
An evidence-based exploration of Matrixyl Peptide and its applications. Analysis of clinical data, mechanisms, and exper...
An evidence-based exploration of Rhode Peptide Lip Liner and its applications. Analysis of clinical data, mechanisms, an...
An evidence-based exploration of What Is Peptides Therapy and its applications. Analysis of clinical data, mechanisms, a...
An evidence-based exploration of Pure Health Peptides and its applications. Analysis of clinical data, mechanisms, and e...
An evidence-based exploration of Peptides And Antioxidants and its applications. Analysis of clinical data, mechanisms, ...
An evidence-based exploration of Nad Peptide For Sale and its applications. Analysis of clinical data, mechanisms, and e...
PeptaVolt
License: BUS-2018-09134-MA
GMP: GMP-2023-6103-US
ISO: ISO 9001:2015 / ISO 13485:2016